Drug Shortage Report for TEVA-LENOLTEC NO. 1
| Report ID | 97594 |
| Drug Identification Number | 00653233 |
| Brand name | TEVA-LENOLTEC NO. 1 |
| Common or Proper name | LENOLTEC NO.1 CAPLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
| Strength(s) | 300MG 8MG 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100's & 200's |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-31 |
| Estimated end date | 2020-07-31 |
| Actual end date | 2020-07-22 |
| Shortage status | Resolved |
| Updated date | 2020-07-23 |
| Company comments | Allocating to 100% of our market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v32 | 2020-07-23 | French | Compare |
| v31 | 2020-07-23 | English | Compare |
| v30 | 2020-06-11 | French | Compare |
| v29 | 2020-06-11 | English | Compare |
| v28 | 2020-05-21 | French | Compare |
| v27 | 2020-05-21 | English | Compare |
| v26 | 2020-05-08 | French | Compare |
| v25 | 2020-05-08 | English | Compare |
| v24 | 2020-04-23 | French | Compare |
| v23 | 2020-04-23 | English | Compare |
| v22 | 2020-04-02 | French | Compare |
| v21 | 2020-04-02 | English | Compare |
| v20 | 2020-03-05 | French | Compare |
| v19 | 2020-03-05 | English | Compare |
| v18 | 2020-02-07 | French | Compare |
| v17 | 2020-02-07 | English | Compare |
| v16 | 2020-01-30 | French | Compare |
| v15 | 2020-01-30 | English | Compare |
| v14 | 2019-12-12 | French | Compare |
| v13 | 2019-12-12 | English | Compare |